Skip to main content
Susan Woods, MD, Dermatology, Austintown, OH, Mercy Health - St. Elizabeth Youngstown Hospital

SusanGWoodsMD

Dermatology Austintown, OH

Dermatologic Surgery

Owner Private Practice

Dr. Woods is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Woods' full profile

Already have an account?

Summary

  • Dr. Susan Woods is a dermatologist in Austintown, OH and is affiliated with multiple hospitals in the area, including Mercy Health - St. Elizabeth Youngstown Hospital, Salem Regional Medical Center, and Steward Health Systems. She received her medical degree from Tufts University School of Medicine and has been in practice 26 years. She specializes in dermatologic surgery and is experienced in sclerotherapy, atopic dermatitis, contact dermatitis, psoriasis, and lasers.

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Dermatology, 1992 - 1995
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 1991 - 1992
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1991
  • University of California, Berkeley
    University of California, BerkeleyBS, summa cum laude

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1994 - 2025
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow (FASDS) American Society for Dermatologic Surgery
  • Fellow (FAAD) American Academy of Dermatology

Research History

  • Principal InvestigatorEspprit: A ten year post marketing observational registry to assess long term safety of Adalimumab (Humira) in Adult Patients with Chronic Plaque Psoriasis2008 - Present
  • Principal investigator5 year Safety Study for etanercept (Enbrel) for psoriasis2006 - 2013
  • principal investigatorSafety and efficacy of Intravenous Alefacept (Amevive) for psoriasis Phase 22001 - 2003
  • Principal investigatorPhase 1 trial for platelet derived growth factor for wound healing1995 - 1997

Professional Memberships

Hospital Affiliations